|
|
Volumn 39, Issue 4, 1996, Pages 711-712
|
|
Sulfasalazine in psoriatic arthritis: A new or established indication?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C REACTIVE PROTEIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
SALAZOSULFAPYRIDINE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LETTER;
NAUSEA;
PRIORITY JOURNAL;
PSORIATIC ARTHRITIS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RISK BENEFIT ANALYSIS;
TOXIC EPIDERMAL NECROLYSIS;
|
|
EID: 0029872445
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.1780390431 Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|
